Anna Giannakouros is a mother of three, retired from a career in the Software Industry. She was diagnosed with Multiple Sclerosis (MS) in 2009 and the disease has currently progressed to the Secondary Progressive stage. Her current mission is to live life in the present and enjoy life to the fullest. She’s an inspiring disability and chronic illness advocate who enjoys blogging and a following on Instagram.  She’s an ambulatory power-chair user driven by a health and fitness lifestyle and enjoys cooking and following a Paleo and Keto eating regime.

In 2003, after suffering with symptoms since the early 1990’s, I was diagnosed with Multiple Sclerosis. As a high school teacher, I educated my school community and raised awareness so much that my MS Walk team consisted of upwards of 400 walkers. In 2011 I learned that I had broken at least 1 vertebra (line due to a fall thanks to MS) and underwent spinal fusion and decompression surgery, and continued to educate my community. Sadly, I became unable to perform
My job anymore and became disability retired in 2014. As I struggled to regain my strength and walk again, I found my way to meditation as a coping mechanism for the extreme sadness I felt, and the depression that was all encompassing. As I began to regain some strength I also incorporated light yoga to keep my body moving and my brain mindful. At the end of 2016 (12/30 to be exact), I was diagnosed with breast cancer. Just like everything else in my life I put a smile on my face and did what I had to, and today I am more than 4 years cancer free. During it all I leaned on yoga and meditation because they are the best non-medicinal tools I know. I even became a yoga teacher so that I could share the benefits of the practice with others because I know first-hand how well it works. Just when I thought I had been given all that I could handle, I was then diagnosed with diabetes in 2018. While I certainly have had my share of obstacles, never once have I asked “why me?”. What I always say is “why not me?”, because I am no better or worse than anyone else and I clearly am swimming in a very shallow gene pool. One thing that has been constant for me is helping others, whether it has been advocating at doctor appointments, helping navigate the difficult waters to SSDI, teaching free yoga classes, or simply talking on the phone with those who need help. From where I stand, despite it all, life is incredibly sweet and I am grateful for every single day.

Dawn Morgan was diagnosed with Multiple Sclerosis when she was 25 years old. Little did she know two decades later she would become a bold patient leader, podcaster, and advocate. Dawn is the cohost of the Myelin & Melanin podcast where Dawn and her cohost interview patients, well known MS specialists, award winning authors, musical artists, actors, and vloggers who are themselves living with MS, or have a unique perspective on the condition and its community. With over 45,000 unique podcast downloads she strives to spotlight the varied and often unheard voices of those within the MS community. Throughout her journey, Dawn’s work has led her to be part of patient advisory committees, an advocate for women’s health overall, partner to Shift MS and Healthline. Dawn has also been featured in publications such as Well+Good, WebMD, Momentum, and Brain & Life, and MS International Federation global face of MS YouTube campaign. Despite her diagnosis she feels that MS has made her a better and stronger person. Dawn is dedicated to using her platform to amplify the many voices of MS.

Julie A. Stamm was diagnosed with Multiple Sclerosis (MS) in 2007. Following her diagnosis, Julie made it her mission to educate, advocate, and support others battling the disease. She works tirelessly to help lessen the burden each patient has to bear. Her efforts have given her the opportunity to work with physicians, patients, and foundations across the Globe. After the birth of her son in 2016, Julie shifted her focus to supporting the children of parents with a chronic illness. Her children’s book entitled “Some Days We….”  was created to normalize differing abilities and amplify how each of us can thrive in spite of the challenges. The movement she has created has changed the apologetic tone and transformed the child and parent’s experiences into uplifting stories that highlight the patient’s resilience.

Brooke Slick is a spirited MS advocate, podcast host and blogger who counsels and connects with patients of all levels of disability from around the world.

Since MS entered her life 19 years ago, she has taken the long and unpredictable walk from able-bodied go-getter to disabled motivator. She draws on her personal experience of living through the physical decline of a once able body to thrive beyond the disability with a positive outlook that transcends any physical shortcomings.

If there is a bright side to a situation, she is going to find it and she’s not going to rest until you are able to pull yourself into the light as well. Her personal mantra, ‘disabled does not mean unable’ is a guiding force behind her message. She vows to empower people living with MS by helping to recalibrate the way they think about themselves and their future with a potentially disabling disease. She wants them to know there is happiness and worthiness to be found beyond your diagnosis.

Brooke’s time spent blogging her multiple sclerosis treatment journey while living in Moscow, Russia, for her followers from over 90 countries at www.msslick.com, and continuing to blog her everyday life at www.brookeslick.com has served her well as she transitioned to full-time advocate. Saying out loud what others are thinking but are afraid to share is her forte. She believes truth telling can heal the soul and free you of a self-encumbered future.

Since May of 2019, she’s used her voice and connections within the MS community as a host of The MS Gym Podcast with download numbers doubling since she came on board. Never wanting to miss out on any segment of the MS community, her episodes have featured anything from applying for Social Security disability, to diets, to depression. Most recently, she was asked to host the MS Gym’s 2020 Virtual Thrive Summit where she interviewed renowned experts in the fields of telemedicine, anxiety, nutrition and the MS connection to the Epstein Barr virus. Brooke’s story has been shared in publications such as the book and podcast, Healthcare Elsewhere, as well as many newspapers, newscasts and medical publications. Using her own experience as a stepping stone, for the past seven years she has been the lead admin for a global group of 7000+ members seeking stem cell transplants for various autoimmune diseases. In addition, she has a loyal following from the autoimmune sector on Instagram and Facebook.

Last, but definitely not least, Brooke created and subsequently patented a versatile mobility/assistive device aimed at providing its users with the independence, relevance and engagement in life that they deserve. She is currently seeking manufacturers to entertain licensing the device while providing international distribution to users in need around the globe. Originally from Pennsylvania, with a legal, medical and marketing background, Brooke spent 10 years based in New York City while traveling the world, and five more in South Florida where her daughter was born, before returning to her roots in Pennsylvania with her husband, Doug.

Watch the Replay:

Join us for an informal, chat-style discussion between the 2021 Innovation Challenge Winner, Pierluigi Mantovani of Evolution Devices, Honorable Mentions, Lucy Jones of FFORA and Tish Scholnik of GRIT, and Judges, Dr. Stephen Squinto of OrbiMed and Patient Ambassador Teresa Wright Johnson, moderated by Lyfebulb CEO Karin Hehenberger, MD, PhD.

If you are interested in hearing first-hand how individuals in the MS community have taken the burden of living with chronic disease, and turned it into a strength to help others, then don’t miss this Fireside Chat. The conversation will spotlight patient entrepreneurship and how patients, working together with industry, is key for the future.

This event, part of our fireside chat series, will spotlight innovative solutions and adaptations, developed by patient entrepreneurs, in order to reduce the burden of MS. We will be sure to discuss today’s MS research landscape as well as what looks most promising for patients.

The conversation will take place at 4pm EST on March 16, 2021.

Evolution Devices has been awarded the $25,000 Innovation Award for its smart stimulation therapy to improve the mobility of multiple sclerosis patients

NEW YORK, March 11, 2021 – Bristol Myers Squibb, the biopharmaceutical company that discovers, develops and delivers innovative medicines to help patients prevail over serious diseases, and Lyfebulb, a patient-empowerment platform that connects patients with industry to support user-driven innovation, are excited to announce that Pierluigi Mantovani of Evolution Devices was chosen as the winner of the “Addressing Unmet Needs in MS: An Innovation Challenge”. 

Evolution Devices will receive $25,000 from Lyfebulb to further develop its innovative, functional electrical stimulation device that couples artificial intelligence and proprietary software to rehabilitate foot drop in multiple sclerosis patients. Pierluigi was motivated to start his company out of his personal observations of seeing his own father struggle with foot drop living with MS.

Additionally, FFORA and GRIT each received honorable mentions for their impactful innovations that have the potential to greatly increase the quality of life for individuals living with MS. FFORA, founded by Lucy Jones, offers a suite of lifestyle branded, wheelchair-attachable products specifically made for the disability community. GRIT, co-founded by Tish Scolnik, offers adaptive, all-terrain wheelchairs allowing people with physical limitations the freedom to engage in outdoor activities.

“At Bristol Myers Squibb, patients are at the heart of everything we do. The caliber of entries and the ingenuity they represent exemplifies the importance of sourcing solutions from those with the most intimate knowledge of Multiple Sclerosis – people with this disease and their loved ones,” said Tina Deignan, Senior Vice President and U.S. Business Unit Head of Immunology at Bristol Myers Squibb. “This partnership with Lyfebulb represents one of many with the MS community and we are truly appreciative of all the time donated from those who submitted entries and the esteemed panel of judges.”

The 2021 MS Innovation Challenge took place virtually over two days on March 10-11, 2021, and was open to entrepreneurs motivated by a personal connection to the disease developing products and solutions for the MS community. Ten finalists were selected to pitch their company’s solution to a panel of independent judges from across industries, including MS experts, healthcare, and the business world. Selected solutions from finalists spanned mobility assistance and wearable devices, transportation accessibility services, exercise and strength training programs, functional accessories, and social enterprises fostering inclusion.

To continue partnership efforts to collectively raise awareness of MS and spotlight innovation, Bristol Myers Squibb and Lyfebulb will be hosting a virtual speaker session with Pierluigi, Lucy and Tish and select judges on March 16, 2021. The speaker session is open to all members of the community, and more information may be found on Lyfebulb.com.

“The degree of impact of the solutions presented by applicants at this year’s challenge was extremely high and we would like to congratulate all those working to improve the lives of those affected by MS,” said Dr. Karin Hehenberger, Founder and CEO of Lyfebulb. “We thank the judges for making this difficult decision in selecting the winner, and hope all entrepreneurs are inspired by the collaborative sessions in this Innovation Challenge to continue on their quest to bring forth solutions to ease the burden of living with chronic disease.”

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

See BMS.com, LinkedInTwitterYouTubeFacebook, and Instagram.

About Lyfebulb

Lyfebulb is a chronic disease-focused, patient empowerment platform that connects patients and industry to support user-driven innovation. With its strong foundation in diabetes, the company has expanded disease states covered into cancer, inflammatory bowel disease, multiple sclerosis, mental health, substance use disorder, migraine, transplantation, psoriasis, chronic cough and chronic kidney disease. See Lyfebulb.comFacebookTwitterInstagramKarin Hehenberger LinkedIn, and Lyfebulb LinkedIn.

About Multiple Sclerosis

Multiple sclerosis (MS) is an unpredictable and often disabling disease that affects nearly one million people in the United States.[i]  MS is a disease in which the immune system attacks the protective myelin sheath that covers the nerves. The myelin damage disrupts communication between the brain and the rest of the body.[ii] Ultimately, the nerves themselves may deteriorate — a process that’s currently irreversible.[iii]

For more information:

Bristol Myers Squibb Contact:

Claire Gillespie
Director, Corporate Affairs, U.S. Immunology Communications, Bristol Myers Squibb
Phone: +1 908-938-4343
Email: Claire.Gillespie@bms.com

Lyfebulb Contact:

Karin Hehenberger, MD, PhD
CEO & Founder, Lyfebulb
Phone: + 1 917-575-0210
Email: karin@lyfebulb.com


[i] National Multiple Sclerosis Society. MS Symptoms. https://www.nationalmssociety.org/Symptoms-Diagnosis/MS-Symptoms. Accessed September 24, 2020.

[ii] National Multiple Sclerosis Society. What is Myelin? www.nationalmssociety.org/What-is-MS/Definition-of-MS/Myelin. Accessed July 07, 2020.

[iii] AJMC. The Pathologic Foundations of Multiple Sclerosis: Current Considerations. https://www.ajmc.com/view/the-pathologic-foundations-of-multiple-sclerosis-current-considerations. Accessed September 24, 2020.

Ten patient entrepreneurs have been shortlisted as finalists in the Lyfebulb and Bristol Myers Squibb “Addressing Unmet Needs in MS: An Innovation Challenge” which has an award of $25,000

NEW YORK – (February 9, 2021) – Bristol Myers Squibb, the biopharmaceutical company that discovers, develops and delivers innovative medicines to help patients prevail over serious diseases, and Lyfebulb, a patient-empowerment platform that connects patients with industry to support user-driven innovation, announce ten finalists chosen for the Lyfebulb-Bristol Myer Squibb “Addressing Unmet Needs in MS: An Innovation Challenge”. 

For two days in March (10th-11th), the following finalists will compete virtually for a grant of $25,000 to further develop their ideas and concepts that will address the unmet needs of people who are suffering from multiple sclerosis (MS). This award will also assist in raising an overall awareness about this chronic disease.

  • Angie Conley, Founder and CEO of Abilitech Medical
  • Jason DaSilva, Founder and President of AXS Lab
  • Luanne  Dibernardo, Founder and CEO of Oro Sports
  • Peter Grande, Co-Founder of MUVE
  • David Hojah, CEO of Parrots
  • Lucy Jones, Founder and CEO of FFORA
  • David Lyons, Founder and Director of MS Fitness Challenge
  • Pierluigi Mantovani, CEO of Evolution Devices
  • Tish Scolnik, Co-Founder and CEO of GRIT
  • Brooke  Slick, Founder and Product Developer of Dashco

“Patients are innovators and problem-solvers.” said Dr. Karin Hehenberger, CEO and Founder of Lyfebulb. “Each of these finalists is an attestation to the power of patient entrepreneurship as they have taken their hardships of living with disease – or observing it in a loved one – and have turned those insights into business solutions to help other members of the MS community. We are excited to bring together these inspirational leaders with our expert panel of judges and members of the Lyfebulb and Bristol Myers Squibb teams for an engaging and interactive two-day summit.”

As a Patient Entrepreneur, each and every one of the finalists has been personally affected by Multiple Sclerosis as either a patient, a support partner, or by having had a loved one diagnosed with the disease. During the virtual Innovation Challenge in March, each finalist will be given the opportunity to pitch their solution to a diverse cross section of professionals from across the MS, healthcare and business worlds. The panel judges will include:

  • Tim Coetzee, PhD, Chief Advocacy, Services and Research Officer at National Multiple Sclerosis Society
  • Kate Cronin, Global CEO of Ogilvy Health
  • Teresa Wright Johnson, MS Patient Ambassador at Lyfebulb and Inspirational Speaker
  • Darin T. Okuda, MD, MS, FAAN, FANA, Director of the Neuroinnovation Program and Director of the Multiple Sclerosis and Neuroimmunology Imaging Program at UT Southwestern Medical Center
  • Stephen Squinto, PhD, Executive Partner at OrbiMed and Co-Founder of Alexion

“MS is an ever-changing disease, and Bristol Myers Squibb is grateful to be partnering with Lyfebulb in supporting the entrepreneurs and creators who are looking for inventive new ways to better the lives of those who are living with this unpredictable disease,” said Tina Deignan, Vice President and US Business Unit Head of Immunology at Bristol Myers Squibb.

For further information about the “2021 MS Innovation Challenge”, visit Lyfebulb.com.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

See BMS.com, LinkedInTwitterYouTubeFacebook, and Instagram.

About Lyfebulb

Lyfebulb is a chronic disease-focused, patient empowerment platform that connects patients and industry to support user-driven innovation. With its strong foundation in diabetes, the company has expanded disease states covered into cancer, inflammatory bowel disease, multiple sclerosis, mental health, substance use disorder, migraine, transplantation, psoriasis, chronic cough and chronic kidney disease. See Lyfebulb.comFacebookTwitterInstagramKarin Hehenberger LinkedIn, and Lyfebulb LinkedIn.

About Multiple Sclerosis

Multiple sclerosis (MS) is an unpredictable and often disabling disease that affects nearly one million people in the United States.[i]  MS is a disease in which the immune system attacks the protective myelin sheath that covers the nerves. The myelin damage disrupts communication between the brain and the rest of the body.[ii] Ultimately, the nerves themselves may deteriorate — a process that’s currently irreversible.[iii]

For more information:

Bristol Myers Squibb Contact:

Claire Gillespie
Director, Corporate Affairs, U.S. Immunology Communications, Bristol Myers Squibb
Phone: +1 908-938-4343
Email: Claire.Gillespie@bms.com

Lyfebulb Contact:

Karin Hehenberger, MD, PhD
CEO & Founder, Lyfebulb
Phone: + 1 917-575-0210
Email: karin@lyfebulb.com


[i] National Multiple Sclerosis Society. MS Symptoms. https://www.nationalmssociety.org/Symptoms-Diagnosis/MS-Symptoms. Accessed September 24, 2020.

[ii] National Multiple Sclerosis Society. What is Myelin? www.nationalmssociety.org/What-is-MS/Definition-of-MS/Myelin. Accessed July 07, 2020.

[iii] AJMC. The Pathologic Foundations of Multiple Sclerosis: Current Considerations. https://www.ajmc.com/view/the-pathologic-foundations-of-multiple-sclerosis-current-considerations. Accessed September 24, 2020.

This content is password protected. To view it please enter your password below: